Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?

Machine-learning techniques keep improving efficiency in one industry after another. One corner of the economy where investors expect another big leap forward is the world of drug development.For every commercial-stage drug out there that generates millions and sometimes billions in annual sales, there were thousands of new drug candidates that didn't get across the finish line. You don't need a life-science background to see an opportunity to streamline this process with help from artificial intelligence ( ...